HealthQuill India
India’s federal government has told state authorities to identify emergency COVID-19 hotspots and ramp up testing, vaccination, and hospital infrastructure as the virus spreads in the South Asian nation.
Health Medical Pharma

India tells states to ramp up COVID-19 emergency procedures 

 HQ Team April 8, 2023: India’s federal government has told state authorities to identify emergency COVID-19 hotspots and ramp up testing, vaccination, and.

Read More
Dr. Reddy’s Laboratories, an Indian maker of generics and active pharmaceutical ingredients, has completed the acquisition of Mayne Pharma’s U.S. generic prescription portfolio.
Drugs Health Medical Pharma

Dr. Reddy’s completes Mayne Pharma’s U.S. portfolio buyout

H.Q. Team April 7, 2023: Dr. Reddy’s Laboratories, an Indian maker of generics and active pharmaceutical ingredients, has completed the acquisition of Mayne.

Read More
Photo by Kamila Maciejewska on Unsplash
Drugs Medical Pharma

Global Pharma recalls eye drops in US after ‘possible’ contamination

The CDC laboratory testing identified the presence of the outbreak strain in opened EzriCare bottles with different lot numbers collected from two states. 

Read More
India has granted a complete customs duty exemption for the personal use of medicines to treat rare diseases, including Merc & Co’s Keytruda for cancer therapy.
Drugs Health Pharma

India fully exempts import tax for drugs treating rare diseases

India has granted a complete customs duty exemption for the personal use of medicines to treat rare diseases, including Merc & Co’s Keytruda.

Read More
India's Jain Irrigation merged its international irrigation business with Israel-based Rivulis Pte. through a cash and stock transaction to reduce consolidated debt, according to a BSE filing.
Climate Health

Jain Irrigation merges with Israel’s Rivulis to cut consolidated debt

India's Jain Irrigation merged its international irrigation business with Israel-based Rivulis Pte. through a cash and stock transaction to reduce consolidated debt, according.

Read More
Indian billionaire Azim Premji's private equity and venture capitalist arm, Premji Invest, and Tube Investments, together will acquire Lotus Surgicals for INR 3.8 billion, according to a BSE filing.
Drugs Medical Pharma

Indian billionaires to buy Lotus Surgicals for INR 3.8 billion

Indian billionaire Azim Premji's private equity and venture capitalist arm, Premji Invest, and Tube Investments, together will acquire Lotus Surgicals for INR 3.8.

Read More
ndia’s Technology Development Board has signed a pact with Huwel Lifesciences for the validation and commercialisation of rapid real-time PCR reagents for storage and transport at room temperature.
Drugs Medical Pharma

India inks pact with Huwel Lifesciences to make rapid real-time PCR reagents

ndia’s Technology Development Board has signed a pact with Huwel Lifesciences for the validation and commercialisation of rapid real-time PCR reagents for storage.

Read More
India has put a cap on the trade margin of 42 selected non-scheduled anti-cancer medicines, including ribociclib, which is used to treat breast cancer.
Drugs Health Pharma

India caps trade margins on 42 anti-cancer medicines

India has put a cap on the trade margin of 42 selected non-scheduled anti-cancer medicines, including ribociclib, which is used to treat breast.

Read More
The WHO has issued a medical product alert on a contaminated cancer and autoimmune disease treatment drug made by Hyderabad, India-based Celon Laboratories, after Yemen and Lebanon raised concerns.
Drugs Medical Pharma

Yemen, Lebanon allege India’s Celon Labs’ drug ‘substandard’

The WHO has issued a medical product alert on a contaminated cancer and autoimmune disease treatment drug made by Hyderabad, India-based Celon Laboratories,.

Read More
A ransomware group has breached the information security network of India's Sun Pharmaceuticals unit, and there is a possibility that "file systems, business and personal data" might have been compromised.
Drugs Medical Pharma

Ransomware group behind cyberattack: Sun Pharma

A ransomware group has breached the information security network of India's Sun Pharmaceuticals unit, and there is a possibility that "file systems, business and personal.

Read More